MEETING PREVIEW: Companies and trends to watch at JP Morgan conference
This article was originally published in Scrip
Executive Summary
Since both seasoned life science investors and relative newcomers to the sector will have time over the holidays to rest prior to the annual JP Morgan Healthcare conference in San Francisco, Big Pharma executives and small biotech CEOs alike may want to spend their time out of the office in late December and early January perfecting answers to investor questions about research, acquisition, product launch and reimbursement strategies for 2013.